Thrivent Financial for Lutherans’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-37,950
| Closed | -$1.75M | – | 2486 |
|
|
2023
Q2 | $1.75M | Sell |
37,950
-1,861
| -5% | -$85.9K | ﹤0.01% | 1429 |
|
|
2023
Q1 | $1.6M | Buy |
39,811
+2,825
| +8% | +$113K | ﹤0.01% | 1452 |
|
|
2022
Q4 | $1.71M | Sell |
36,986
-11,483
| -24% | -$532K | ﹤0.01% | 1355 |
|
|
2022
Q3 | $2.01M | Buy |
48,469
+11,483
| +31% | +$475K | 0.01% | 1214 |
|
|
2022
Q2 | $2.21M | Buy |
+36,986
| New | +$2.21M | 0.01% | 1181 |
|
|
2022
Q1 | – | Sell |
-20,757
| Closed | -$1.75M | – | 2575 |
|
|
2021
Q4 | $1.75M | Buy |
+20,757
| New | +$1.75M | ﹤0.01% | 1484 |
|
|
2018
Q2 | – | Sell |
-8,801
| Closed | -$449K | – | 2028 |
|
|
2018
Q1 | $449K | Buy |
+8,801
| New | +$449K | ﹤0.01% | 1695 |
|